Goldman Sachs’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-262,373
| Closed | -$1.35M | – | 5039 |
|
|
2024
Q2 | $1.35M | Sell |
262,373
-184,218
| -41% | -$951K | ﹤0.01% | 3441 |
|
|
2024
Q1 | $2.39M | Buy |
446,591
+206,910
| +86% | +$1.11M | ﹤0.01% | 3098 |
|
|
2023
Q4 | $1.87M | Buy |
239,681
+133,149
| +125% | +$1.04M | ﹤0.01% | 3252 |
|
|
2023
Q3 | $421K | Buy |
106,532
+1,111
| +1% | +$4.39K | ﹤0.01% | 3953 |
|
|
2023
Q2 | $332K | Buy |
105,421
+189
| +0.2% | +$595 | ﹤0.01% | 4186 |
|
|
2023
Q1 | $281K | Buy |
105,232
+92,824
| +748% | +$248K | ﹤0.01% | 4376 |
|
|
2022
Q4 | $44.5K | Buy |
+12,408
| New | +$44.5K | ﹤0.01% | 4805 |
|
|
2022
Q3 | – | Sell |
-24,307
| Closed | -$234K | – | 5697 |
|
|
2022
Q2 | $234K | Buy |
24,307
+2,647
| +12% | +$25.5K | ﹤0.01% | 4831 |
|
|
2022
Q1 | $257K | Sell |
21,660
-27,829
| -56% | -$330K | ﹤0.01% | 4962 |
|
|
2021
Q4 | $1.61M | Buy |
49,489
+439
| +0.9% | +$14.3K | ﹤0.01% | 3645 |
|
|
2021
Q3 | $2.19M | Sell |
49,050
-1,072
| -2% | -$47.9K | ﹤0.01% | 3416 |
|
|
2021
Q2 | $2.73M | Sell |
50,122
-13,570
| -21% | -$740K | ﹤0.01% | 3261 |
|
|
2021
Q1 | $4.76M | Buy |
63,692
+51,904
| +440% | +$3.88M | ﹤0.01% | 2703 |
|
|
2020
Q4 | $1.28M | Buy |
11,788
+2,581
| +28% | +$280K | ﹤0.01% | 3324 |
|
|
2020
Q3 | $814K | Buy |
9,207
+2,920
| +46% | +$258K | ﹤0.01% | 3420 |
|
|
2020
Q2 | $670K | Buy |
6,287
+1,694
| +37% | +$181K | ﹤0.01% | 3449 |
|
|
2020
Q1 | $272K | Sell |
4,593
-567
| -11% | -$33.6K | ﹤0.01% | 3813 |
|
|
2019
Q4 | $357K | Buy |
5,160
+1,515
| +42% | +$105K | ﹤0.01% | 3802 |
|
|
2019
Q3 | $378K | Buy |
3,645
+1,776
| +95% | +$184K | ﹤0.01% | 3697 |
|
|
2019
Q2 | $173K | Sell |
1,869
-539
| -22% | -$49.9K | ﹤0.01% | 3913 |
|
|
2019
Q1 | $220K | Buy |
2,408
+37
| +2% | +$3.38K | ﹤0.01% | 3853 |
|
|
2018
Q4 | $132K | Buy |
2,371
+1,100
| +87% | +$61.2K | ﹤0.01% | 3845 |
|
|
2018
Q3 | $151K | Sell |
1,271
-5,203
| -80% | -$618K | ﹤0.01% | 3871 |
|
|
2018
Q2 | $661K | Buy |
6,474
+5,183
| +401% | +$529K | ﹤0.01% | 3404 |
|
|
2018
Q1 | $168K | Buy |
+1,291
| New | +$168K | ﹤0.01% | 3905 |
|
|
2017
Q1 | – | Sell |
-1,396
| Closed | -$170K | – | 4569 |
|
|
2016
Q4 | $170K | Sell |
1,396
-1,550
| -53% | -$189K | ﹤0.01% | 3946 |
|
|
2016
Q3 | $409K | Buy |
2,946
+946
| +47% | +$131K | ﹤0.01% | 3542 |
|
|
2016
Q2 | $363K | Buy |
+2,000
| New | +$363K | ﹤0.01% | 3529 |
|